Centene (CNC) Projected to Release Quarterly Earnings on Tuesday

Centene (NYSE:CNC) is expected to be releasing its Q2 2026 results before the market opens on Tuesday, July 28th. Analysts expect Centene to announce earnings of $1.08 per share and revenue of $47.6405 billion for the quarter. Parties can check the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Tuesday, July 28, 2026 at 8:30 AM ET.

Centene (NYSE:CNC) last announced its quarterly earnings data on Tuesday, April 28th. The company reported $3.37 earnings per share for the quarter, beating the consensus estimate of $2.23 by $1.14. Centene had a positive return on equity of 5.57% and a negative net margin of 3.25%.The company had revenue of $49.94 billion during the quarter, compared to analysts’ expectations of $47.53 billion. During the same quarter last year, the company earned $2.90 EPS. Centene’s revenue for the quarter was up 7.1% compared to the same quarter last year. On average, analysts expect Centene to post $3 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Centene Stock Performance

Shares of NYSE CNC opened at $65.88 on Tuesday. Centene has a 52 week low of $25.08 and a 52 week high of $69.36. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.12 and a current ratio of 1.12. The stock has a 50 day moving average price of $62.95 and a 200 day moving average price of $49.08. The stock has a market capitalization of $32.53 billion, a PE ratio of -5.01, a price-to-earnings-growth ratio of 0.52 and a beta of 1.07.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the business. DV Equities LLC bought a new stake in Centene during the 4th quarter worth approximately $26,000. IFC & Insurance Marketing Inc. bought a new stake in Centene during the 4th quarter valued at $28,000. McMillan Office Inc. purchased a new stake in shares of Centene in the fourth quarter worth about $49,000. Intesa Sanpaolo Wealth Management bought a new stake in Centene during the fourth quarter valued at $60,000. Finally, BOKF NA purchased a new stake in Centene in the third quarter valued at approximately $69,000. 93.63% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research analysts have recently commented on the stock. Jefferies Financial Group lifted their price objective on shares of Centene from $39.00 to $48.00 and gave the company a “hold” rating in a research report on Wednesday, April 29th. Wells Fargo & Company set a $69.00 price objective on Centene and gave the stock an “equal weight” rating in a research report on Monday, July 13th. Royal Bank Of Canada lifted their price target on shares of Centene from $70.00 to $71.00 and gave the company a “sector perform” rating in a research report on Thursday, July 9th. Mizuho set a $63.00 price target on Centene and gave the company a “neutral” rating in a research note on Monday, June 8th. Finally, Barclays restated an “overweight” rating on shares of Centene in a research note on Tuesday, June 16th. Seven investment analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, Centene has a consensus rating of “Hold” and a consensus price target of $64.61.

Centene Company Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.